Özdemir Serpil, Akkaya Rabia, Karaşahin Kazım Emre
Department of Public Health Nursing, University of Health Sciences Turkey, Gülhane Faculty of Nursing, Ankara, Turkey
Department of Obstetrics and Gynecology, University of Health Sciences Turkey, Gülhane Training and Research Hospital, Ankara, Turkey
J Turk Ger Gynecol Assoc. 2020 Jun 8;21(2):111-123. doi: 10.4274/jtgga.galenos.2019.2019.0071. Epub 2019 Aug 9.
Human papilloma virus (HPV) vaccine is a proven method for preventing HPV-related cancers and genital warts, especially preventing cervical cancer. It is aimed to systematically review and synthesize conclusions in detail from community-based studies published in Turkey between 2009 and 2019, which evaluate the knowledge, awareness, attitude, and behaviors of individuals towards HPV and HPV vaccination. This systematic review is conducted based on the PRISMA reporting method and includes community-based, descriptive cross-sectional and cross-sectional studies published between 2009 and 2019. In this systematic review, 5132 studies from six databases were scanned in total. It was determined that there were 23 studies that met the eligibility criteria for this systematic review. In the reviewed studies, it was determined that the rate of “Hearing of HPV before” was 3.8% at the lowest and 57.0% at the highest, and the rate of “Hearing of HPV vaccine before” was 2.2% at the lowest and 74.7% at the highest. In the reviewed studies, it was reported that although parents’ willingness to have their daughters vaccinated with HPV vaccine varied between 14.4% and 68.0%, their willingness to have their sons vaccinated with HPV vaccine varied between 11.0% and 62.0%. In addition, it was reported that the lowest rate of vaccination with HPV vaccine among participants was 0.3% at the lowest and 6.0% at the highest. Consequently, it is considered that conducting common, systematic, and continuous health education programs aimed at both sexes and including both parents, which will increase the knowledge and awareness on HPV and its vaccine, would provide positive attitudes, and will be effective in protecting against HPV-related cancers.
人乳头瘤病毒（HPV）疫苗是预防HPV相关癌症和尖锐湿疣的一种经证实的方法，尤其是预防宫颈癌。本研究旨在系统回顾并详细综合2009年至2019年间在土耳其发表的基于社区的研究中的结论，这些研究评估了个体对HPV和HPV疫苗接种的知识、意识、态度及行为。本系统评价基于PRISMA报告方法进行，纳入2009年至2019年间发表的基于社区的描述性横断面和横断面研究。在本系统评价中，共检索了六个数据库中的5132项研究。确定有23项研究符合本系统评价的纳入标准。在纳入的研究中，“之前听说过HPV”的比例最低为3.8%，最高为57.0%，“之前听说过HPV疫苗”的比例最低为2.2%，最高为74.7%。在纳入的研究中，报告称，尽管父母让女儿接种HPV疫苗的意愿在14.4%至68.0%之间有所不同，但他们让儿子接种HPV疫苗的意愿在11.0%至62.0%之间有所不同。此外，报告称参与者中HPV疫苗接种率最低为0.3%，最高为6.0%。因此，认为开展针对男女两性且包括父母双方的共同、系统和持续的健康教育项目，将增加对HPV及其疫苗的知识和认识，会产生积极态度，并将有效预防HPV相关癌症。
